Business
ReWalk Robotics Announces the Appointment of Joseph E. Turk, Jr. to their Board of Directors
Seasoned Medical Device professional brings 25 years of experience in commercializing novel technologies and in new business development MARLBOROUGH, Mass.
About this update from Lifeward Ltd.
[{"type":"text","content":"Seasoned Medical Device professional brings 25 years of experience in commercializing novel technologies and in new business development\nMARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 20, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics. Ltd. (NASDAQ: RWLK) (“ReWalk” or “The Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, announced today that the Board has approved the appointment of Joseph Turk, Jr. to the Board of Directors, effective today. After initiating his career at McKinsey and Company, Mr. Turk has assembled an extensive history in the medical device industry beginning with his role as Director of New Business Development at Boston Scientific. Subsequently, he held multiple roles at NxStage Medical, including President, where he led all commercialization activities including securing favorable Medicare payment policies; overseeing all commercial functions for the implementation and growth of their key products; and coordinating key M&A efforts for building the company. Currently, he is an Executive Vice President at Fresenius Medical Care North America (FMC-NA) and the President of the Renal Therapies Group. Prior to that he was the President of FMC-NA’s Home and Critical Care Therapies efforts. “Being able to improve people’s lives through commercializing novel technologies has been a driving force in my career,” said Turk. “Working with a mission-driven company with life-changing technologies such as ReWalk is a natural fit. I look forward to contributing my insight to help ReWalk develop successful broad commercialization strategies that enable better health for the disabled community, all within the context of a sustainable business model.” “As ReWalk is now preparing for implementation of broader commercialization efforts based on an anticipated expanded coverage position in Germany and the United States, we sought to increase direct commercialization skills and experience within our Board,” said Jeff Dykan, Chairman of the Board of Directors at ReWalk Robotics, “Joe has a successful track record of development and implementation, and we believe his experience is highly valuable to our goals in developing the company. We are thrilled to welcome him to the Board.” For more information, please visit rewalk.com. About ReWalk Robotics Ltd.ReWalk Robotics Ltd. ...